文献速递肝病

2000至2020年美国慢性肝病与肝硬化死亡率在年轻女性中不成比例地增加

Chronic Liver Disease and Cirrhosis Mortality Rates Are Disproportionately Increasing in Younger Women in the United States Between 2000-2020.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-11-28

该研究基于美国国家卫生统计中心数据库,分析2000至2020年慢性肝病与肝硬化死亡率的性别、年龄、种族和地理趋势。总体及老年人群中男女死亡率增长相似,但年轻成人(<55岁)中女性年均百分比变化大于男性(AAPC=3.04 vs 1.08,差值1.96,P<.001),差异主要由非西班牙裔白人和西班牙裔驱动,并存在州际差异。

要点

  • 2000至2020年美国慢性肝病与肝硬化死亡共716,651例,女性占35.68%。
  • 年轻成人中女性死亡率增长快于男性(AAPC=3.04 vs 1.08,差值1.96,P<.001)。
  • 差异主要由非西班牙裔白人和西班牙裔驱动,并在16个州观察到。

核心结论

  • 美国慢性肝病与肝硬化死亡率在年轻女性中不成比例地增加。
  • 该发现由非西班牙裔白人和西班牙裔人群较高增长率驱动,并存在美国各州间差异。
  • 未来研究有必要识别这些趋势的原因,最终目标是改善结局。

研究设计与样本

  • 基于美国国家卫生统计中心数据库的时间趋势分析,收集2000至2020年慢性肝病与肝硬化死亡率(年龄调整至2000年美国标准人口)。
  • 按性别和年龄分为老年成人(≥55岁)与年轻成人(<55岁),并按种族、美国州和肝硬化病因分类。
  • 使用Joinpoint回归及蒙特卡洛置换分析估计时间趋势、年度百分比变化(APC)和平均年度百分比变化(AAPC)。
  • 采用平行性和同一性检验进行性别特异性两两比较(双侧P值 cutoff = .05)。

主要发现

  • 2000至2020年美国共有716,651例死亡归因于慢性肝病与肝硬化(35.68%为女性)。
  • 总体人群和老年成人中,男性和女性慢性肝病与肝硬化相关死亡率增长相似。
  • 年轻成人(246,149例死亡,32.72%为女性)中,女性增长率大于男性(AAPC=3.04 vs 1.08,AAPC差值=1.96;P<.001),数据非同一且非平行(P值<.001)。
  • 差异由非西班牙裔白人(AAPC=4.51 vs 1.79,AAPC差值=2.71;P<.001)和西班牙裔(AAPC=1.89 vs -0.65,AAPC差值=2.54;P=.001)驱动。
  • 差异在美国各州间不同,见于16个州,主要在西弗吉尼亚州(AAPC=4.96 vs 0.88,AAPC差值=4.08;P<.001)和宾夕法尼亚州(AAPC=2.81 vs -1.02,AAPC差值=3.84;P<.001);病因特异性分析未显示年轻成人中显著的性别差异。

局限性

  • 未来研究有必要识别这些趋势的原因,最终目标是改善结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Previous studies show that mortality from chronic liver disease (CLD) and cirrhosis is increasing in the United States. However, there are limited data on sex-specific mortality trends by age, race, and geographical location. The aim of this study was to conduct a comprehensive time-trend analysis of liver disease-related mortality rates in the National Center of Health Statistics (NCHS) database. METHODS: CLD and cirrhosis mortality rates between 20002020 (age-adjusted to the 2000 standard U.S. population) were collected from the NCHS database and categorized by sex and age into older adults (≥55 years) and younger adults (<55 years), race (Non-Hispanic-White, Non-Hispanic-Black, Hispanic, Non-Hispanic-American-Indian/Alaska-Native, and Non-Hispanic-Asian/Pacific-Islander), U.S. state, and cirrhosis etiology. Time trends, annual percentage change (APC), and average APC (AAPC) were estimated using Joinpoint Regression using Monte Carlo permutation analysis. We used tests for parallelism and identicalness for sex-specific pairwise comparisons of mortality trends (two-sided P value cutoff = .05). RESULTS: Between 20002020, there were 716,651 deaths attributed to CLD and cirrhosis in the U.S. (35.68% women). In the overall population and in older adults, CLD and cirrhosis-related mortality rates were increasing similarly in men and women. However, in younger adults (246,149 deaths, 32.72% women), the rate of increase was greater in women compared with men (AAPC = 3.04 vs 1.08, AAPC-difference = 1.96; P < .001), with non-identical non-parallel data (P values < .001). The disparity was driven by Non-Hispanic-White (AAPC = 4.51 vs 1.79, AAPC-difference = 2.71; P < .001) and Hispanic (AAPC = 1.89 vs -0.65, AAPC-difference = 2.54; P = .001) individuals. The disparity varied between U.S. states and was seen in 16 states, mostly in West Virginia (AAPC = 4.96 vs 0.88, AAPC-difference = 4.08; P < .001) and Pennsylvania (AAPC = 2.81 vs -1.02, AAPC-difference = 3.84; P < .001). Etiology-specific analysis did not show significant sex disparity in younger adults. CONCLUSIONS: Mortality rates due to CLD and cirrhosis in the U.S. are increasing disproportionately in younger women. This finding was driven by higher rates in Non-Hispanic White and Hispanic individuals, with variation between U.S. states. Future studies are warranted to identify the reasons for these trends with the ultimate goal of improving outcomes.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Abboud Y, Mathew AG, Meybodi MA, et al. Chronic Liver Disease and Cirrhosis Mortality Rates Are Disproportionately Increasing in Younger Women in the United States Between 2000-2020. Clin Gastroenterol Hepatol. 2023. PMID: 38036281. doi:10.1016/j.cgh.2023.11.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。